| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/10/2004 | CA2506037A1 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| 06/10/2004 | CA2505757A1 Genetic products differentially expressed in tumors and the use thereof |
| 06/10/2004 | CA2504144A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |
| 06/10/2004 | CA2476691A1 Novel proteins and nucleic acids encoding same |
| 06/09/2004 | EP1426764A1 Method of diagnosing or monitoring saccharometabolic error |
| 06/09/2004 | EP1425694A2 Method of identifying a consensus sequence for intracellular antibodies |
| 06/09/2004 | EP1425389A2 Human antibodies specific for interleukin 15 (il-15) |
| 06/09/2004 | EP1425380A2 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 06/09/2004 | EP1425302A2 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 06/09/2004 | EP1425299A2 Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination |
| 06/09/2004 | EP1425297A2 Isolation of neural stem cells using gangliosides and other surface markers |
| 06/09/2004 | EP1425289A2 Novel nucleic acid and polypeptide molecules |
| 06/09/2004 | EP1425085A2 High strength asymmetric cellulosic membrane |
| 06/09/2004 | EP1425042A1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 06/09/2004 | EP1425041A2 Methods for sterilizing preparations of monoclonal immunoglobulins |
| 06/09/2004 | EP1425036A2 Virus coat protein/receptor chimeras and methods of use |
| 06/09/2004 | EP1425028A2 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 06/09/2004 | EP1424906A1 Method and apparatus for separation of milk, colostrum, and whey |
| 06/09/2004 | EP1381866B1 Process for differential diagnosis of alzheimer's dementia and device therefor |
| 06/09/2004 | EP1064005A4 Urokinase plasminogen activator receptor as a target for diagnosis of metastases |
| 06/09/2004 | EP1054687A4 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 06/09/2004 | EP0809510B1 Lymphotoxin-alpha/beta complexes and anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 06/09/2004 | EP0589928B1 Cold tolerances in plants |
| 06/09/2004 | CN1503806A Pepties from the 16/6id antibody for treating SLE |
| 06/09/2004 | CN1503680A Ascorbic a cid analogs for metalloradiopharmaceuticals |
| 06/09/2004 | CN1502697A Alzhimer's disease secretase |
| 06/09/2004 | CN1502696A Alzheimer's disease secretase |
| 06/09/2004 | CN1502692A Alzheimer's disease secretase |
| 06/09/2004 | CN1502630A Monocloned antibody of O6-methylguanine-DNA methyltransferase preparation process and test kit |
| 06/09/2004 | CN1502626A Novel human protein with cancer-inhibiting function and coding sequence thereof |
| 06/09/2004 | CN1152960C ICAM-4 materials and methods |
| 06/09/2004 | CN1152957C Human 6-phosphoglucosamine isomerase, its code sequence and application |
| 06/08/2004 | US6747143 Methods for polymer synthesis |
| 06/08/2004 | US6747136 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen |
| 06/08/2004 | US6747134 Antibody immunologically reactive with serine protease EOS |
| 06/08/2004 | US6747131 Phosphorylated fusion proteins |
| 06/08/2004 | US6747130 Tenebrio antifreeze proteins |
| 06/08/2004 | US6746871 Bacillus crystal proteins having improved insecticidal activity; immunodetection kits; transgenic plants |
| 06/08/2004 | US6746866 Preparation of factor XIIIa by gene manipulation |
| 06/08/2004 | US6746865 Nucleic acids encoding for endostatin protein |
| 06/08/2004 | US6746847 Diagnostic assay for human matrix Gla-protein and its use as a biomarker |
| 06/08/2004 | US6746673 For prophylaxis and/or treatment of an autoimmune disease or rheumatoid arthritis |
| 06/08/2004 | CA2112702C Assay methods and compositions for detecting serum proteases, particularly activated protein c |
| 06/08/2004 | CA2064814C Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 06/03/2004 | WO2004046733A1 Non-competitive immunoassay for small analytes |
| 06/03/2004 | WO2004046380A1 Psoriasis diagnostics and therapeutics |
| 06/03/2004 | WO2004046355A2 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 06/03/2004 | WO2004046330A2 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization |
| 06/03/2004 | WO2004046310A2 Novel mouse polypeptides encoded by polynucleotides and methods of their use |
| 06/03/2004 | WO2004046306A2 Fully human antibody fab fragments with human interferon-gamma neutralizing activity |
| 06/03/2004 | WO2004046195A1 Monoclonal antibodies against n-terminus probnp |
| 06/03/2004 | WO2004046194A2 Polyclonal-monoclonal elisa assay for detecting n-terminus probnp |
| 06/03/2004 | WO2004046193A1 Method of acquiring human monoclonal antibody inhibting cancer cell proliferation |
| 06/03/2004 | WO2004046192A2 Method for isolating intracellular antibodies able to neutralize protein interactions |
| 06/03/2004 | WO2004046191A2 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis |
| 06/03/2004 | WO2004046190A2 Antibodies lacking vacuolar targeting signal peptide and capable of binding j-chain |
| 06/03/2004 | WO2004046189A2 Method for generating immunoglobulin genes |
| 06/03/2004 | WO2004046188A2 Anti-activated ras antibodies |
| 06/03/2004 | WO2004046187A2 Antibodies for in vitro use |
| 06/03/2004 | WO2004046186A2 Intrabodies against the oncogenic form of ras |
| 06/03/2004 | WO2004046185A2 Intracellular antibodies |
| 06/03/2004 | WO2004046182A2 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 06/03/2004 | WO2004045643A1 Remedy for chondroma or chondrosarcoma |
| 06/03/2004 | WO2004045642A1 Use of multi-specific, non-covalent complexes for targeted delivery of therapeutics |
| 06/03/2004 | WO2004045638A1 Vanilloid receptor-2 ligands for treating anxiety or depression |
| 06/03/2004 | WO2004045553A2 Ca125 gene and its use for diagnostic and therapeutic interventions |
| 06/03/2004 | WO2004045544A2 Autocrine growth factor receptor antibodies and methods |
| 06/03/2004 | WO2004045532A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 06/03/2004 | WO2004045526A2 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 06/03/2004 | WO2004045525A2 Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation. |
| 06/03/2004 | WO2004045520A2 Complement receptor 2 targeted complement modulators |
| 06/03/2004 | WO2004045519A2 Induction of apoptosis by hiv-1 infected monocytic cells |
| 06/03/2004 | WO2004045516A2 Compositions and methods for the diagnosis and treatment of tumor |
| 06/03/2004 | WO2004045512A2 Human monoclonal antibodies against cd25 |
| 06/03/2004 | WO2004045507A2 Anti-angiogenic uses of il-6 antagonists |
| 06/03/2004 | WO2004045379A2 Biomarkers for intra-amniotic inflammation |
| 06/03/2004 | WO2004039401A3 Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis |
| 06/03/2004 | WO2004032838A8 Methods for treating cancer by inhibiting wnt signaling |
| 06/03/2004 | WO2004029093A3 Humanized anti-granulocyte mn-3 antibody and uses thereof |
| 06/03/2004 | WO2004025416A3 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 06/03/2004 | WO2004024769A3 Ostertagia vaccine |
| 06/03/2004 | WO2004024084A9 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 06/03/2004 | WO2004018519A3 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 06/03/2004 | WO2003106974A3 Diagnosis and treatment of chemoresistant tumors |
| 06/03/2004 | WO2003102183A9 Pramyxovirus vectors encoding antibody and utilization thereof |
| 06/03/2004 | WO2003100029A3 Mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use |
| 06/03/2004 | WO2003097796A3 T7 bacteriophage display of fabs |
| 06/03/2004 | WO2003096022A8 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
| 06/03/2004 | WO2003095493A3 Toxin-related antibodies with antimicrobial and antiviral activity |
| 06/03/2004 | WO2003089475A3 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
| 06/03/2004 | WO2003089450A3 Fusion polypeptides and methods for inhibiting microbial adhesion |
| 06/03/2004 | WO2003088995A3 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 06/03/2004 | WO2003079025A3 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof |
| 06/03/2004 | WO2003068920A9 Humanized gm-csf antibodies |
| 06/03/2004 | WO2003062415A3 Transgenic animal comprising intracellular immunoglobins for xenotransplantation |
| 06/03/2004 | WO2003059245A3 Method of treating asthma |
| 06/03/2004 | WO2003054544A3 Method for determination of the responsiveness of an individual to mistletoe lectin |
| 06/03/2004 | WO2002078608A8 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 06/03/2004 | WO2002060954A8 Materials and methods for treatment of hepatitis c |
| 06/03/2004 | WO1997035010A8 Chemokine alpha 2 |